Inhaltsbereich
| 56 Einträge | 1, 2, 3 › » |
Seite 1 / 3
 Druckansicht
|
| Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015. |
| Gillessen S, Omlin A, Attard G, de Bono JS, Efstathiou E, Fizazi K, Halabi S, Nelson PS, Sartor O, Smith MR, Soule HR, Akaza H, Beer TM, Beltran H, Chinnaiyan AM, Daugaard G, Davis ID, De Santis M, Drake CG, Eeles RA, Fanti S, Gleave ME, Heidenreich A, Hussain M, James ND, Lecouvet FE, Logothetis CJ, Mastris K, Nilsson S, Oh WK, Olmos D, Padhani AR, Parker C, Rubin MA, Schalken JA, Scher HI, Sella A, Shore ND, Small EJ, Sternberg CN, Suzuki H, Sweeney CJ, Tannock IF, Tombal B |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 Jun 3. pii: mdv257. doi: 10.1093/annonc/mdv257. pmc: PMC4511225 |
| PMID: 26041764 |
| SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer. |
| Eichelberg C, Vervenne WL, De Santis M, Fischer von Weikersthal L, Goebell PJ, Lerchenmüller C, Zimmermann U, Bos MM, Freier W, Schirrmacher-Memmel S, Staehler M, Pahernik S, Los M, Schenck M, Flörcken A, van Arkel C, Hauswald K, Indorf M, Gottstein D, Michel MS |
| European urology. 2015 May 4. pii: S0302-2838(15)00319-X. doi: 10.1016/j.eururo.2015.04.017 |
| PMID: 25952317 |
| Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial. |
| Sternberg CN, Skoneczna I, Kerst JM, Albers P, Fossa SD, Agerbaek M, Dumez H, de Santis M, Théodore C, Leahy MG, Chester JD, Verbaeys A, Daugaard G, Wood L, Witjes JA, de Wit R, Geoffrois L, Sengelov L, Thalmann G, Charpentier D, Rolland F, Mignot L, Sundar S, Symonds P, Graham J, Joly F, Marreaud S, Collette L, Sylvester R |
| The Lancet. Oncology. 2014 Dec 11. pii: S1470-2045(14)71160-X. doi: 10.1016/S1470-2045(14)71160-X |
| PMID: 25498218 |
| Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer. |
| Oldenburg J, Aparicio J, Beyer J, Cohn-Cedermark G, Cullen M, Gilligan T, De Giorgi U, De Santis M, de Wit R, Fosså SD, Germà-Lluch JR, Gillessen S, Haugnes HS, Honecker F, Horwich A, Lorch A, Ondruš D, Rosti G, Stephenson AJ, Tandstad T |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2014 Nov 6. pii: mdu514. doi: 10.1093/annonc/mdu514 |
| PMID: 25378299 |
| Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up. |
| Bellmunt J, Orsola A, Leow JJ, Wiegel T, De Santis M, Horwich A |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2014 Aug 5. pii: mdu223. doi: 10.1093/annonc/mdu223 |
| PMID: 25096609 |
| The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review. |
| Bruins HM, Veskimae E, Hernandez V, Imamura M, Neuberger MM, Dahm P, Stewart F, Lam TB, N'Dow J, van der Heijden AG, Compérat E, Cowan NC, De Santis M, Gakis G, Lebret T, Ribal MJ, Sherif A, Witjes JA |
| European urology. 2014 Jul 26. pii: S0302-2838(14)00491-6. doi: 10.1016/j.eururo.2014.05.031 |
| PMID: 25074764 |
| Combined chemoradiotherapy with gemcitabine in patients with locally advanced inoperable transitional cell carcinoma of the urinary bladder and/or in patients ineligible for surgery: a phase I trial. |
| De Santis M, Bachner M, Cerveny M, Kametriser G, Steininger T, Königsberg R, Schratter-Sehn A, Sedlmayer F, Dittrich C |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2014 Jun 16. pii: mdu209. doi: 10.1093/annonc/mdu209 |
| PMID: 24936582 |
| Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel. |
| Fitzpatrick JM, Bellmunt J, Fizazi K, Heidenreich A, Sternberg CN, Tombal B, Alcaraz A, Bahl A, Bracarda S, Di Lorenzo G, Efstathiou E, Finn SP, Fosså S, Gillessen S, Kellokumpu-Lehtinen PL, Lecouvet FE, Oudard S, de Reijke TM, Robson CN, De Santis M, Seruga B, de Wit R |
| European journal of cancer (Oxford, England : 1990). 2014 Apr 3. pii: S0959-8049(14)00253-6. doi: 10.1016/j.ejca.2014.03.010 |
| PMID: 24703899 |
| EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. |
| Witjes JA, Compérat E, Cowan NC, De Santis M, Gakis G, Lebret T, Ribal MJ, Van der Heijden AG, Sherif A |
| European urology. 2013 Dec 12. pii: S0302-2838(13)01310-9. doi: 10.1016/j.eururo.2013.11.046 |
| PMID: 24373477 |
| Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1). |
| De Santis M, Wiechno PJ, Bellmunt J, Lucas C, Su WC, Albiges L, Lin CC, Senkus-Konefka E, Flechon A, Mourey L, Necchi A, Loidl WC, Retz MM, Vaissière N, Culine S |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 Dec 16. pii: mdv609. doi: 10.1093/annonc/mdv609 |
| PMID: 26673352 |
| Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma. |
| Choueiri TK, Escudier B, Powles T, Mainwaring PN, Rini BI, Donskov F, Hammers H, Hutson TE, Lee JL, Peltola K, Roth BJ, Bjarnason GA, Géczi L, Keam B, Maroto P, Heng DY, Schmidinger M, Kantoff PW, Borgman-Hagey A, Hessel C, Scheffold C, Schwab GM, Tannir NM, Motzer RJ |
| The New England journal of medicine. 2015 Sep 25. doi: 10.1056/NEJMoa1510016 |
| PMID: 26406150 |
| Immunotherapies for bladder cancer: a new hope. |
| Fakhrejahani F, Tomita Y, Maj-Hes A, Trepel JB, De Santis M, Apolo AB |
| Current opinion in urology. 2015 Oct 2. doi: 10.1097/MOU.0000000000000213 |
| PMID: 26372038 |
| ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition 2016. |
| Dittrich C, Kosty M, Jezdic S, Pyle D, Berardi R, Bergh J, El Saghir N, Lotz JP, Österlund P, Pavlidis N, Purkalne G |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2016 Jul 26. pii: mdw239. doi: 10.1093/annonc/mdw239 |
| PMID: 27457308 |
| Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trials. |
| Caffo O, Thompson C, De Santis M, Kragelj B, Hamstra DA, Azria D, Fellin G, Pappagallo GL, Galligioni E, Choudhury A |
| Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. pii: S0167-8140(16)34304-3. doi: 10.1016/j.radonc.2016.09.006 |
| PMID: 27720221 |
| ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016. |
| Dittrich C, Kosty M, Jezdic S, Pyle D, Berardi R, Bergh J, El-Saghir N, Lotz JP, Österlund P, Pavlidis N, Purkalne G, Awada A, Banerjee S, Bhatia S, Bogaerts J, Buckner J, Cardoso F, Casali P, Chu E, Close JL, Coiffier B, Connolly R, Coupland S, De Petris L, De Santis M, de Vries EG, Dizon DS, Duff J, Duska LR, Eniu A, Ernstoff M, Felip E, Fey MF, Gilbert J, Girard N, Glaudemans AW, Gopalan PK, Grothey A, Hahn SM, Hanna D, Herold C, Herrstedt J, Homicsko K, Jones DV, Jost L, Keilholz U, Khan S, Kiss A, Köhne CH, Kunstfeld R, Lenz HJ, Lichtman S, Licitra L, Lion T, Litière S, Liu L, Loehrer PJ, Markham MJ, Markman B, Mayerhoefer M, Meran JG, Michielin O, Moser EC, Mountzios G, Moynihan T, Nielsen T, Ohe Y, Öberg K, Palumbo A, Peccatori FA, Pfeilstöcker M, Raut C, Remick SC, Robson M, Rutkowski P, Salgado R, Schapira L, Schernhammer E, Schlumberger M, Schmoll HJ, Schnipper L, Sessa C, Shapiro CL, Steele J, Sternberg CN, Stiefel F, Strasser F, Stupp R, Sullivan R, Tabernero J, Travado L, Verheij M, Voest E, Vokes E, Von Roenn J, Weber JS, Wildiers H, Yarden Y |
| ESMO open. doi: 10.1136/esmoopen-2016-000097. pii: esmoopen-2016-000097 |
| PMID: 27843641 |
| Randomized phase II/III trial assessing gemcitabine/carboplatin (GC) and methotrexate/carboplatin/vinblastine (M-CAVI) in patients (pts) with advanced urothelial cancer (UC) "unfit" for cisplatin based chemotherapy (CHT): Updated phase II results and risk group analysis of EORTC study 30986. |
| De Santis M, Bellmunt Molins J, de Wit R, Mead B, Kerst JM, Leahy M, Maroto P, Skoneczna IA, Marreaud S, Sylvester RJ |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Jan 1. pii: 10.1200/jco.2008.26.15_suppl.5031 |
| PMID: 27948842 |
| A randomized phase III study comparing paclitaxel-BEP (T-BEP) to standard BEP in patients with in intermediate prognosis germ cell cancer (GCC): An intergroup study of EORTC, German TCSG/AUO, MRC, and Spanish GCC group (EORTC 30983). |
| De Wit R, Skoneczna IA, Gedske Daugaard K, de Santis M, Garin A, Aass N, Witjes JA, Albers P, White J, Germa-Lluch JR, Osanto S, Marreaud S, Collette L |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.4509 |
| PMID: 28023466 |
| 835PUPDATED OS ANALYSIS, MULTIVARIATE AND QTWIST ANALYSIS OF A RANDOMIZED SEQUENTIAL OPEN-LABEL STUDY (SWITCH) TO EVALUATE EFFICACY AND SAFETY OF SORAFENIB (SO) / SUNITINIB (SU) VERSUS SU/SO IN THE TREATMENT OF METASTATIC RENAL CELL CANCER (MRCC). |
| Eichelberg C, Goebell PJ, Vervenne WL, De Santis M, Fischer von Weikersthal L, Lerchenmüller C, Zimmermann U, Bos MM, Freier W, Schirrmacher-Memmel S, Staehler M, Pahernik S, Los M, Schenck M, Floercken A, van Arkel C, Hauswald K, Indorf M, Gottstein D, Michel M |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241552. doi: 10.1093/annonc/mdu337.28 |
| PMID: 28172251 |
| 812PDMATURE SURVIVAL (OS) DATA OF A RANDOMISED INTERNATIONAL PHASE II TRIAL (JASINT1): VINFLUNINE (VFL)-GEMCITABINE (GEM) VS. VFL-CBDCA IN CDDP-UNFIT PATIENTS (PTS) WITH ADVANCED UROTHELIAL CARCINOMA (UC). |
| De Santis M, Wiechno PJ, Lucas C, Lin C, Su W, Bellmunt J, Legrand K, Fougeray R, Culine S |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241576. doi: 10.1093/annonc/mdu337.5 |
| PMID: 28171465 |
| 807TiPA PROSPECTIVE, MULTINATIONAL OBSERVATIONAL STUDY OF MEN WITH LATER-STAGE PROSTATE CANCER, A NEW GLOBAL STUDY TO EXAMINE PATTERNS OF CARE AND OUTCOMES. |
| De Santis M, Cooperberg MR, Chang Y, Clarke NW, Costello AJ, Pickles T, Curiel R, Pompeo AC |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2238946. doi: 10.1093/annonc/mdu336.54 |
| PMID: 28170526 |
| 56 Einträge | 1, 2, 3 › » |
Seite 1 / 3
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
